Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results

GoodRx Holdings, Inc. (GDRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/22/2023 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 50,337 shares @ $6.72, valued at $338.3k
Exercised 91,025 restricted stock units @ $0
08/10/2023 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 4,379 shares @ $8.68, valued at $38k
Exercised 12,662 restricted stock units @ $0
08/10/2023 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 17,506 shares @ $8.68, valued at $152k
Exercised 31,656 restricted stock units @ $0
07/18/2023 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 902 shares @ $7.46, valued at $6.7k
Exercised 2,606 restricted stock units @ $0
06/15/2023 4 REY-GIRAUD AGNES (Director) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 39,177 shares @ $0
06/15/2023 4 Bradley Julie MB (Director) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 39,177 shares @ $0
06/12/2023 4 Azad Babak (See Remarks) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 7,055 shares @ $5.41, valued at $38.2k
Exercised 20,401 restricted stock units @ $0
06/12/2023 4 Voermann Karsten (CFO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 16,611 shares @ $5.41, valued at $89.9k
Exercised 54,064 restricted stock units @ $0
06/12/2023 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 3,528 shares @ $5.41, valued at $19.1k
Exercised 10,201 restricted stock units @ $0
06/01/2023 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 202,603 restricted stock units @ $0
Granted 276,900 options to buy @ $5.53, valued at $1.5M
06/01/2023 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 506,508 restricted stock units @ $0
Granted 692,252 options to buy @ $5.53, valued at $3.8M
05/22/2023 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 43,797 shares @ $5.08, valued at $222.5k
Exercised 91,026 restricted stock units @ $0
05/15/2023 4 Wagner Scott (See Remarks) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 3,000,000 options to buy @ $5.1, valued at $15.3M
04/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/09/2023 4 Voermann Karsten (CFO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 17,397 shares @ $5.5, valued at $95.7k
Exercised 54,064 restricted stock units @ $0
03/09/2023 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 4,160 shares @ $5.5, valued at $22.9k
Exercised 10,201 restricted stock units @ $0
03/09/2023 4 Azad Babak (See Remarks) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 8,089 shares @ $5.5, valued at $44.5k
Exercised 20,402 restricted stock units @ $0
02/22/2023 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 37,604 shares @ $5.29, valued at $198.9k
Exercised 91,025 restricted stock units @ $0
01/17/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/18/2022 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 902 shares @ $6.15, valued at $5.5k
Paid exercise price by delivering 902 shares @ $4.75, valued at $4.3k
Exercised 2,606 restricted stock units @ $0
Exercised 2,606 restricted stock units @ $0
09/26/2022 4 Nabiey Romin (Chief Accounting Officer) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 163,212 restricted stock units @ $0
Granted 273,030 restricted stock units @ $5.25, valued at $1.4M
09/26/2022 4 Voermann Karsten (CFO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 865,023 restricted stock units @ $0
09/26/2022 4 Azad Babak (See Remarks) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 326,424 restricted stock units @ $0
09/06/2022 4 Bezdek Trevor (Co-CEO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Converted 129,374 shares @ $0
Exercised 256,594 restricted stock units @ $0
Exercised 256,594 options to buy @ $0
Paid exercise price by delivering 127,220 options to buy @ $6.1, valued at $776k
Converted 129,374 options to buy @ $0
09/06/2022 4 Hirsch Douglas Joseph (Co-CEO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Converted 129,374 shares @ $0
Exercised 256,594 restricted stock units @ $0
Exercised 256,594 options to buy @ $0
Paid exercise price by delivering 127,220 options to buy @ $6.1, valued at $776k
Converted 129,374 options to buy @ $0
08/23/2022 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Paid exercise price by delivering 37,838 shares @ $6, valued at $227k
Exercised 91,026 restricted stock units @ $0
06/21/2022 4 Beri Raj (COO) has filed a Form 4 on GoodRx Holdings, Inc.
Txns: Granted 1,456,408 restricted stock units @ $0
Granted 1,788,419 options to buy @ $5.94, valued at $10.6M
06/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy